AGÕæÈ˹ٷ½

STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

PTC Therapeutics (NASDAQ: PTCT) has scheduled its second quarter 2025 financial results conference call for Thursday, August 7, at 4:30 p.m. ET. The presentation will include financial results and a business update. Participants are advised to register in advance and dial in 15 minutes before the call to avoid delays.

The webcast will be accessible through PTC's investor relations website, with a replay available for 30 days after the presentation.

PTC Therapeutics (NASDAQ: PTCT) ha programmato la conference call per la presentazione dei risultati finanziari del secondo trimestre 2025 per giovedì 7 agosto, alle 16:30 ET. La presentazione includerà i risultati finanziari e un aggiornamento sull'attività aziendale. Si consiglia ai partecipanti di registrarsi in anticipo e di collegarsi 15 minuti prima dell'inizio per evitare ritardi.

La trasmissione in webcast sarà disponibile attraverso il sito web delle relazioni con gli investitori di PTC, con una replica accessibile per 30 giorni dopo la presentazione.

PTC Therapeutics (NASDAQ: PTCT) ha programado su llamada de conferencia para los resultados financieros del segundo trimestre de 2025 para el jueves 7 de agosto a las 4:30 p.m. ET. La presentación incluirá resultados financieros y una actualización del negocio. Se recomienda a los participantes registrarse con anticipación y conectarse 15 minutos antes de la llamada para evitar demoras.

La transmisión en vivo estará disponible a través del sitio web de relaciones con inversionistas de PTC, con una repetición accesible durante 30 días después de la presentación.

PTC Therapeutics (NASDAQ: PTCT)ëŠ� 2025ë…� 2분기 재무 ê²°ê³¼ 컨í¼ëŸ°ìФ ì½œì„ 8ì›� 7ì� 목요ì� 오후 4ì‹� 30ë¶�(ë™ë¶€ì‹œê°„)ì—� 예정하고 있습니다. 발표ì—는 재무 결과와 사업 ì—…ë°ì´íŠ¸ê°€ í¬í•¨ë©ë‹ˆë‹�. 참가ìžëŠ” ì§€ì—°ì„ ë°©ì§€í•˜ê¸° 위해 사전ì—� 등ë¡í•˜ê³  ì½� 시작 15ë¶� ì „ì— ì ‘ì†í•� ê²ƒì„ ê¶Œìž¥í•©ë‹ˆë‹�.

웹ìºìŠ¤íŠ¸ëŠ� PTCì� 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 ì ‘ì†í•� ìˆ� 있으ë©�, 발표 í›� 30ì� ë™ì•ˆ 다시보기가 제공ë©ë‹ˆë‹�.

PTC Therapeutics (NASDAQ : PTCT) a programmé sa conférence téléphonique sur les résultats financiers du deuxième trimestre 2025 pour le jeudi 7 août à 16h30 ET. La présentation comprendra les résultats financiers ainsi qu'une mise à jour commerciale. Il est conseillé aux participants de s'inscrire à l'avance et de se connecter 15 minutes avant l'appel afin d'éviter tout retard.

Le webcast sera accessible via le site des relations investisseurs de PTC, avec une rediffusion disponible pendant 30 jours après la présentation.

PTC Therapeutics (NASDAQ: PTCT) hat seine Telefonkonferenz zu den Finanzergebnissen des zweiten Quartals 2025 für Donnerstag, den 7. August, um 16:30 Uhr ET angesetzt. Die Präsentation umfasst Finanzergebnisse und ein Geschäftsupdate. Teilnehmer werden gebeten, sich im Voraus zu registrieren und 15 Minuten vor Beginn der Konferenz einzuwählen, um Verzögerungen zu vermeiden.

Das Webcast ist über die Investor-Relations-Website von PTC zugänglich, mit einer Wiederholung, die 30 Tage nach der Präsentation verfügbar ist.

Positive
  • None.
Negative
  • None.

WARREN, N.J., July 21, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2025 financial results and provide an update on the company's business and outlook on Thursday, August 7, at 4:30 p.m. ET.

To access the call by phone, please  to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in for the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at . A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

For more information, please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
[email protected]

Media:
Jeanine Clemente
+1 (908) 912-9406
[email protected]

Cision View original content to download multimedia:

SOURCE PTC Therapeutics, Inc.

FAQ

When is PTC Therapeutics (PTCT) reporting Q2 2025 earnings?

PTC Therapeutics will report its Q2 2025 earnings on Thursday, August 7, at 4:30 p.m. ET.

How can I access PTC Therapeutics Q2 2025 earnings call?

Investors can access the call by registering for dial-in details or watching the webcast through PTC's investor relations website at https://ir.ptcbio.com/events-presentations.

How long will PTC Therapeutics Q2 2025 earnings call replay be available?

The earnings call replay will be available on PTC's website for 30 days after the presentation.

What time should I dial in for PTC Therapeutics Q2 2025 earnings call?

PTC recommends participants dial in 15 minutes before the call's start time (4:30 p.m. ET) to avoid delays.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

3.92B
77.30M
2.46%
100%
4.8%
Biotechnology
Pharmaceutical Preparations
United States
WARREN